Pluri (PLUR) Gains from Investment Securities (2010 - 2025)
Pluri (PLUR) reported Gains from Investment Securities of $9380.0 for Q4 2025, down 22.72% year-over-year from $12138.0 in Q4 2024, and down 53.1% quarter-over-quarter from $20000.0 in Q3 2025.
Pluri (PLUR) Gains from Investment Securities (2010 - 2025) Analysis & Trends
Pluri (PLUR) has 16 years of Gains from Investment Securities data on file, last reported at $9380.0 in Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at $9380.0, down 22.72% year-over-year; the trailing twelve-month figure through Dec 2025 was $9380.0 (down 22.72% YoY), and the FY2025 annual result was $240291.0, up 781.16% from the prior year.
- Gains from Investment Securities retreated to $9380.0 in Q4 2025 per PLUR's latest filing, from $20000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $2.6 million in Q1 2021 and troughed at -$539000.0 in Q2 2025.
- A 5-year average of $254911.9 and a median of $25000.0 in 2023 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2021 and 2025: Gains from Investment Securities jumped 251625.71% in 2021, then slumped 185.72% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $75000.0 in 2021, then surged by 346.43% to $334821.0 in 2022, then surged by 477.87% to $1.9 million in 2023, then plunged by 99.37% to $12138.0 in 2024, then fell by 22.72% to $9380.0 in 2025.
- Business Quant data shows PLUR's Gains from Investment Securities at $9380.0 in Q4 2025, $20000.0 in Q3 2025, and -$539000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Pluri | 20.93 Mn | 21.41 Mn | 86,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9,380.00 |
| Dec 31, 2025 | 9,380.00 |
| Sep 30, 2025 | 20,000.00 |
| Sep 30, 2025 | 20,000.00 |
| Jun 30, 2025 | -539,000.00 |
| Jun 30, 2025 | -539,000.00 |
| Mar 31, 2025 | -17,000.00 |
| Mar 31, 2025 | -17,000.00 |
| Dec 31, 2024 | 12,138.00 |
| Dec 31, 2024 | 12,138.00 |
| Sep 30, 2024 | 18,000.00 |
| Sep 30, 2024 | 18,000.00 |
| Mar 31, 2024 | 19,831.00 |
| Mar 31, 2024 | 19,831.00 |
| Dec 31, 2023 | 1.93 Mn |
| Dec 31, 2023 | 1.93 Mn |
| Sep 30, 2023 | 25,000.00 |
| Sep 30, 2023 | 25,000.00 |
| Jun 30, 2023 | 8,100.00 |
| Jun 30, 2023 | 8,100.00 |